The National Stock Exchange of India (NSE) on Tuesday, January 7 announced the addition of six securities in the Futures & Options (F&O) with effect from January 31, 2025. The stocks that will be included are Castrol India, Gland Pharma, NBCC, Phoenix, Solar Industries India and Torrent Power. The inclusions are based on the stock … Read more
Mumbai: Promoters of more than 200 companies have cumulatively sold stock worth more than ₹33,000 crore in the past two months, suggesting that valuations have become attractive enough for owners to book returns on part of the equity they hold. As the question of stretched valuations continues to swirl through Dalal Street, promoters seem to … Read more
While Nifty ended with modest weak-on-weak gains of 0.4%, the truncated trading week was laden with top action where over three dozen companies from large, mid and smallcap segments witnessed prominent block deals worth Rs 40,543 crore on screen, which included both buying and selling. In the largecap segment, 15 companies witnessed significant block deals … Read more
Shares of Gland Pharma fell up to 6% to the day’s low of Rs 1,745 on BSE in Tuesday’s trade after entities related to ex-promoter Dr Ravi Penmetsa likely sold 5.5% equity in the company. Large block deals of nearly 91 lakh shares were reported today in which shares worth about Rs 1,600 crore changed … Read more
Mumbai: The next four months could see a massive supply of shares, potentially reaching up to $12 billion from about 40 companies, excluding state-owned firms that went public in the last two years. This surge arises as various lock-in periods are set to expire for both promoters and investors who participated in pre-IPO placements. Market … Read more
Indian equities, ahead of the crucial RBI policy outcome on Thursday, ended on a positive note. The Nifty settled at 19,633, up 62 points, while the Sensex added 149 points, settling at 65,996. Sectorally, the trend was mixed with metal and media emerging as top gainers, while realty was the laggard. Here’s how analysts interpret … Read more
Shares of Gland Pharma on Tuesday rallied up to 20% to the day’s high of Rs 1,610 after the company reported better-than-expected June quarter earnings with revenue growing 41% year-on-year (YoY). Global brokerage firm Jefferies upgraded the stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier. Bernstein … Read more
Mutual funds were net buyers in Indian equities in May, adding stocks worth Rs 2,447 crore as compared to selling Rs 4,533 crore in shares in April. In the smallcap space, some of the major additions to the portfolios during the month include Jupiter Wagons, Nexus Select Trust Mall, Carysil, Chennai Petroleum Corp and Faze … Read more
Indian market snapped a 3-day losing streak and closed in the green on Friday. The S&P BSE Sensex rose nearly 300 points while Nifty50 closed above 18200 levels. Sectorally, buying was seen in IT, realty, banks, and autos while selling was visible in healthcare, consumer durables, and public sector stocks. Stocks that were in focus … Read more
Shares of Mankind Pharma will hit the Street on May 9 and grey market trends indicate a healthy listing for the company. According to market sources, the shares of Mankind Pharma are commanding a premium of Rs 120 apiece. Considering the upper price band of Rs 1,080, the company’s shares are expected to list a … Read more